Regulatory Medical Writing Services

Unlock your Regulatory submission's success with Freyr's Regulatory Medical Writing Services. Our experienced team of clinical and nonclinical experts crafts accurate Regulatory documents, ensuring clarity and expertise. With extensive experience in toxicology and complex projects, we deliver high-quality work to various healthcare agencies worldwide.

  • 60

    +

    Experts
  • 20

    +

    Years of Domain Expertise
  • 150

    +

    Customers/Clients
  • 150

    +

    Dossiers Prepared for NDAs, BLAs, MAAs, and 505 b(2)s
  • 2500

    +

    PDE & OEL Reports
  • 500

    +

    Impurities risk assessments
  • 50

    +

    ERA as per EMA 2024 requirements

Regulatory Medical Writing Services - Overview

Medical writing is an indispensable aspect of any Regulatory submission for Pharmaceuticals. Handing clinical and non-clinical modules for Regulatory submission dossiers under medical writing requires an in-depth understanding, experience, and thorough Regulatory knowledge.

Freyr is a significant player in offering Regulatory Medical Writing Services and has expertise due to a team of highly qualified medical writing professionals. Our well-established processes governed by SOPs, checklists, and reviews ensure that high-quality documents are maintained. Our Regulatory medical writing team is flexible in adapting to client-specific processes and templates for developing documents. Such experts' alignment based on project-specific requirements ensures better time management in project completion.

Our Regulatory writing services team is equipped to work with the US, EU, UK, and other regulated and semi-regulated countries.

 

Regulatory Medical Writing Services

  • Preparation and review of Non-Clinical and Clinical Overviews and Summaries (eCTD Modules 2.4, 2.5, 2.6, and 2.7), including the preparation and review of eCTD Modules 4 and 5
  • Preparation and review of the Clinical Study Report (CSR, eCTD Module 5)
  • Preparation and review of the Clinical Trial Protocol (CTP), Investigator Brochure (IB), efficacy and safety summaries, and patient/safety narrative writing
  • Support for Integrated Summaries (ISS, ISE, and ISI)
  • Clinical justification documents for the EU, US, and other emerging Regulatory markets
  • Biowaiver support for product approval and strategic support for study design
  • Abuse liability assessment justification support
  • Clinical (GCP) and bioanalytical (GLP) facility audits provide expertise and support for study-specific monitoring
  • Toxicological Risk Assessment (TRA) of impurities, extractables and leachables, excipients, and industrial chemicals
  • Permitted Daily Exposure (PDE) and Occupational Exposure Level (OEL) calculations
Regulatory Medical Writing Services
  • A team of over sixty (60) clinical and non-clinical medical writing experts
  • In-depth Regulatory medical writing knowledge, like the ICH-GCP, EMA, and FDA guidelines, with IT capabilities integration
  • Vast experience in multiple therapeutic areas like oncology, cardiovascular, psychiatry, respiratory, renal, gastrointestinal, etc.
  • Defined processes of thorough scientific, medical, editorial, and in-house quality control review before the sponsor review
  • Experience in drafting medical writing documents for various phases of clinical development, including Phase I to IV, Post-Marketing Surveillance Studies (PMS), and Post-Authorization Safety Studies (PASS)
  • Timely delivery of medical writing documents with the highest standard of quality
Regulatory Medical Writing Services

Precise Regulatory Writing Starts Here

Get Started with Freyr

Success Stories

Freyr provided Comprehensive Reports for Drug-Device Combination Product: Supported a Swift Toxicological Risk Assessment Case for an Australian Pharma Company Within 48 Hours
Medical Writing

Freyr provided Comprehensive Reports for Drug-Device Combination Product: Supported a Swift Toxicological Risk Assessment Case for an Australian Pharma Company Within 48 Hours

The client, based in Australia, specializes in discovering, developing, and delivering top-quality veterinary pharmaceuticals, faced hindrances in Regulatory processes due to leachable traces in the product. They approached Freyr for a rapid Toxicological Risk Assessment (TRA) focusing on delivering comprehensive reports for a Drug-Device Combination Product. Their specific needs included detecting impurities and ensuring sufficient capabilities for quantification.

Freyr provided Scientific Writing Support to Create a High-Quality Scientific Brochure for an Indian Pharmaceutical and Biotechnology Company in Novel Drug Delivery Systems
Medical Writing

Freyr provided Scientific Writing Support to Create a High-Quality Scientific Brochure for an Indian Pharmaceutical and Biotechnology Company in Novel Drug Delivery Systems

The customer, an Indian multinational pharmaceutical and biotechnology company specializing in active pharmaceutical ingredients (APIs) and generic formulations, due to limited availability of clinical literature they approached Freyr for preparing scientific brochures. These brochures focused on Novel Drug Delivery System products in the field of Virology/Anti-human immunodeficiency virus (HIV) infection for an international conference,

Freyr Supported High-Impact Publication by Supporting Manuscript Preparation for a France-Based Biopharmaceutical Company in Hematology/Anti-thrombotic Therapies
Medical Writing

Freyr Supported High-Impact Publication by Supporting Manuscript Preparation for a France-Based Biopharmaceutical Company in Hematology/Anti-thrombotic Therapies

The customer, based in France, specializes in a novel approach to cardiovascular emergencies. Due to unavailability of clinical literature and challenges encountered in framing a robust study design. They approached Freyr to validate clinical manuscripts in the Hematology/Anti-thrombotic focused therapeutic area, aiming to explore the rigorous methodologies utilized in manuscript development, which encompass robust data analysis and interpretation.

Celebrating Customers Success

 

Medicinal Products

Medical Writing

India

A big thanks to Freyr team for the support they have provided to us on priority. We really appreciate the extra effort that the Freyr team has put into providing the reports on time. We are looking forward for a continuous business association with Freyr.

Head of Quality Assurance

 

Medicinal Products

Medical Writing

India

A big thanks to the Freyr team for the support they have provided to us on priority. We really appreciate the extra effort that the Freyr team has put into providing the reports on time. We are looking forward to a continuous business association with Freyr.​

Head of Quality Assurance​

India-based, Leading Pharma Contract Manufacturing Organization​

 

Medicinal Products

Medical Writing

UK

We are extremely happy to inform you that the BLA was successfully submitted to the FDA. We convey our sincere gratitude to the Freyr team, who worked diligently, tirelessly, and very closely with our Bridgewater and Beijing teams over the past several months to accomplish this monumental feat on time. Freyr’s team went beyond the call of duty to make this BLA submission come true. We truly appreciate Freyr’s flexibility and eagerness to work with us to accomplish aggressive goals. Look forward to your perennial support and our continued relationship and beyond. ​

Global CMC Technical Lead​

China-based, Leading Innovator Pharmaceutical Company​

 

Medicinal Products

Medical Writing

USA

Thank you, Freyr team. I appreciate your professionalism, dedication, and hard work. You’ve gone above and beyond to ensure all deliverables were met ahead of schedule throughout the project and have done a great job managing a challenging group of products. I appreciate your attention to detail and follow-up on the large workload you’ve managed. It’s been a pleasure working with you, and I wish you and your family all the best in the future!​

Director, Global Labeling Management – Labeling Cluster Head Global Product ​ Development, Global Regulatory Affairs

US-based, Multinational Pharmaceutical and Biotechnology Company​

 

Medicinal Products

Medical Writing

Vietnam​

Thank you so much for being a great partner in our Regulatory compliance journey.

As Asian countries move towards having safety assessments as a key requirement, your support has helped us significantly in fulfilling those requirements well ahead of our competitors in Vietnam. ​

In fact, I shared your contact with our regulatory officers so that they can share it across the industry if the safety assessments become necessary.

Lead, R&D/Personal Care

India-based, Multinational Consumer Goods Company​

 

Medicinal Products

Medical Writing

USA

Kudos to you all for the brilliant teamwork !! Alone, we can do so little; together, we can do so much.

Look forward to the next milestone and collaboration on new projects in the future.

SVP - R&D ( Finished Dosage Form)​

US-based, CRO Company that Focuses on Material Science and Engineering for Drug Development​